These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 23042705

  • 1. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.
    Dong YH, Lin HH, Shau WY, Wu YC, Chang CH, Lai MS.
    Thorax; 2013 Jan; 68(1):48-56. PubMed ID: 23042705
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 3. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Rojas-Reyes MX, García Morales OM, Dennis RJ, Karner C.
    Cochrane Database Syst Rev; 2016 Jun 06; 2016(6):CD008532. PubMed ID: 27271056
    [Abstract] [Full Text] [Related]

  • 4. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials.
    Singh S, Loke YK, Enright PL, Furberg CD.
    BMJ; 2011 Jun 14; 342():d3215. PubMed ID: 21672999
    [Abstract] [Full Text] [Related]

  • 5. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
    Hodder R, Kesten S, Menjoge S, Viel K.
    Int J Chron Obstruct Pulmon Dis; 2007 Jun 14; 2(2):157-67. PubMed ID: 18044688
    [Abstract] [Full Text] [Related]

  • 6. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ, Cates CJ, Poole P.
    Cochrane Database Syst Rev; 2010 May 12; (5):CD007891. PubMed ID: 20464758
    [Abstract] [Full Text] [Related]

  • 7. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 8. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul 10; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 9. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent?
    Mathioudakis AG, Chatzimavridou-Grigoriadou V, Evangelopoulou E, Mathioudakis GA, Siafakas NM.
    Pulm Pharmacol Ther; 2014 Aug 10; 28(2):91-7. PubMed ID: 24846455
    [Abstract] [Full Text] [Related]

  • 10. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
    Short PM, Williamson PA, Elder DHJ, Lipworth SIW, Schembri S, Lipworth BJ.
    Chest; 2012 Jan 10; 141(1):81-86. PubMed ID: 21799028
    [Abstract] [Full Text] [Related]

  • 11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 10; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 12. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.
    Verhamme KM, Afonso A, Romio S, Stricker BC, Brusselle GG, Sturkenboom MC.
    Eur Respir J; 2013 Sep 10; 42(3):606-15. PubMed ID: 23520322
    [Abstract] [Full Text] [Related]

  • 13. Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.
    Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D.
    Int J Chron Obstruct Pulmon Dis; 2015 Sep 10; 10():239-59. PubMed ID: 25709423
    [Abstract] [Full Text] [Related]

  • 14. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
    Tricco AC, Strifler L, Veroniki AA, Yazdi F, Khan PA, Scott A, Ng C, Antony J, Mrklas K, D'Souza J, Cardoso R, Straus SE.
    BMJ Open; 2015 Oct 26; 5(10):e009183. PubMed ID: 26503392
    [Abstract] [Full Text] [Related]

  • 15. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
    Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct 26; 12():907-922. PubMed ID: 28360514
    [Abstract] [Full Text] [Related]

  • 16. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 26; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 17. Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long-Acting β2 -Agonists and Inhaled Corticosteroids: The OUTPUL Study.
    Ferroni E, Belleudi V, Cascini S, Di Martino M, Kirchmayer U, Pistelli R, Patorno E, Formoso G, Fusco D, Perucci CA, Davoli M, Agabiti N, OUTPUL Study GroupDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy..
    J Clin Pharmacol; 2016 Nov 26; 56(11):1423-1432. PubMed ID: 27095425
    [Abstract] [Full Text] [Related]

  • 18. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 26; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.
    Kwak MS, Kim E, Jang EJ, Kim HJ, Lee CH.
    Int J Chron Obstruct Pulmon Dis; 2015 Sep 26; 10():2365-76. PubMed ID: 26604734
    [Abstract] [Full Text] [Related]

  • 20. Long-acting bronchodilators and arterial stiffness in patients with COPD: a comparison of fluticasone furoate/vilanterol with tiotropium.
    Pepin JL, Cockcroft JR, Midwinter D, Sharma S, Rubin DB, Andreas S.
    Chest; 2014 Dec 26; 146(6):1521-1530. PubMed ID: 25058845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.